Dolby Laboratories, Inc. (DLB) stock analysis
DLB · Dolby Laboratories, Inc.
Latest recorded price: USD 58.82
Model-estimated fair value: USD 42.04. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Industrials · Specialty Business Services
At $58.82, DLB trades 39.9% above the model's base-case value of $42.04. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $35.55 in the conservative case and $49.35 in the optimistic case, with a valuation confidence score of 85/100. About 71% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2026 figures: revenue growth 3.0%, free cash flow margin 25.3%, ROIC 12.1%. The model flags 1 risk signal for this company.